FGF21 and metabolic syndrome: On the other hand, prospective cohort studies demonstrated that FGF21 resistance precedes the onset of metabolic syndrome and type 2 diabetes in humans, suggesting that higher plasma FGF21 levels are an independent predictor of metabolic syndrome and type 2 diabetes19,20.